Emergent BioSolutions Inc (NYSE:EBS)

12.00
Delayed Data
As of Dec 02
 +0.19 / +1.61%
Today’s Change
11.34
Today|||52-Week Range
52.28
-72.39%
Year-to-Date

Today’s Trading

Previous close11.81
Today’s open11.65
Day’s range11.50 - 12.01
Volume937,696
Average volume (3 months)768,544
Market cap$593.2M
Data as of 4:00pm ET, 12/02/2022

Growth & Valuation

Earnings growth (last year)-25.45%
Earnings growth (this year)-131.63%
Earnings growth (next 5 years)+34.00%
Revenue growth (last year)+15.26%
P/E ratio15.2
Price/Sales1.31
Price/Book0.38

Competitors

 Today’s
change
Today’s
% change
BNGOBionano Genomics Inc+0.10+5.05%
SGMOSangamo Therapeutics...+0.08+2.25%
SRNESorrento Therapeutic...+0.03+2.44%
RAPTRapt Therapeutics In...+0.07+0.40%
Data as of 4:00pm ET, 12/02/2022

Financials

Next reporting dateFebruary 23, 2023
EPS forecast (this quarter)$0.04
Annual revenue (last year)$1.8B
Annual profit (last year)$230.9M
Net profit margin12.88%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Gaithersburg, Maryland

Forecasts